Verloes–David syndrome

Verloes–David Syndrome is a rare genetic disorder characterized by a spectrum of anomalies affecting multiple organ systems. The syndrome was first described by Alain Verloes and Bruno David, who identified its unique clinical features and genetic patterns. Verloes–David Syndrome is considered a complex condition due to its varied manifestations and the genetic heterogeneity associated with it.

Clinical Features

The clinical presentation of Verloes–David Syndrome can vary significantly among affected individuals. However, common features include:

• Craniofacial Anomalies: Patients often exhibit distinct facial features such as a broad forehead, hypertelorism (widely spaced eyes), and a small jaw (micrognathia).
• Neurological Impairments: Developmental delay, intellectual disability, and seizures are frequently reported in individuals with this syndrome.
• Skeletal Abnormalities: These may include scoliosis (curvature of the spine), joint hypermobility, and limb anomalies.
• Cardiac Defects: Congenital heart defects are also common among those diagnosed with Verloes–David Syndrome.

Genetics

Verloes–David Syndrome is believed to follow an autosomal recessive pattern of inheritance. This means that the condition occurs when an individual inherits two copies of an altered gene, one from each parent. The specific genes involved in Verloes–David Syndrome have not been fully identified, making genetic counseling and prediction of the syndrome's occurrence challenging.

Diagnosis

Diagnosis of Verloes–David Syndrome is primarily based on clinical evaluation and the identification of characteristic features. Genetic testing may help in confirming the diagnosis, although the absence of identified causative genes limits this approach. Prenatal diagnosis is challenging due to the syndrome's genetic complexity and variability in clinical presentation.

Management and Treatment

Management of Verloes–David Syndrome is symptomatic and supportive, focusing on the specific needs of the individual. This may include:

• Medical Management: Treatment of cardiac defects, seizure control, and management of other medical issues as they arise.
• Therapeutic Support: Physical therapy, occupational therapy, and speech therapy can help in addressing developmental delays and improving quality of life.
• Educational Support: Tailored educational programs and support can assist individuals with intellectual disabilities in achieving their potential.

Prognosis

The prognosis for individuals with Verloes–David Syndrome varies depending on the severity of the symptoms and the presence of life-threatening complications, such as severe cardiac anomalies. Early intervention and comprehensive care can improve the quality of life and outcomes for those affected.

See Also

• Genetic disorder
• Autosomal recessive inheritance
• Craniofacial anomaly
• Developmental delay

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian